These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 7483340)

  • 1. [Proton pump blockers and their significance in gastroenterology].
    Dítĕ P; Prásek J
    Vnitr Lek; 1995 Aug; 41(8):549-54. PubMed ID: 7483340
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of omeprazole, lansoprazole, pantoprazole, and rabeprazole in the treatment of acid-related diseases.
    Welage LS; Berardi RR
    J Am Pharm Assoc (Wash); 2000; 40(1):52-62; quiz 121-3. PubMed ID: 10665250
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lansoprazole: a proton pump inhibitor.
    Garnett WR
    Ann Pharmacother; 1996 Dec; 30(12):1425-36. PubMed ID: 8968456
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proton-pump inhibitors: three of a kind?
    Bateman DN
    Lancet; 1997 Jun; 349(9066):1637-8. PubMed ID: 9186377
    [No Abstract]   [Full Text] [Related]  

  • 5. An overview of proton pump inhibitors.
    Der G
    Gastroenterol Nurs; 2003; 26(5):182-90. PubMed ID: 14603076
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lansoprazole. A review of its pharmacodynamic and pharmacokinetic properties and its therapeutic efficacy in acid-related disorders.
    Barradell LB; Faulds D; McTavish D
    Drugs; 1992 Aug; 44(2):225-50. PubMed ID: 1382017
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [What are the indications for proton pump inhibitors? R. Arnold, Marburg, elaborates on the clinical aspects of the controversy regarding lansoprazole. Interview by Gerrit Lichtenberg].
    Arnold R
    Fortschr Med; 1994 Jan; 112(1-2):44-5. PubMed ID: 8144120
    [No Abstract]   [Full Text] [Related]  

  • 8. [Proton pump inhibitors in pediatrics].
    Faure C; Pelatan C; Languepin J
    Arch Pediatr; 1999 Jun; 6(6):650-6. PubMed ID: 10394458
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [2 new proton pump inhibitors. Possibilities of pantoprazole and lansoprazole].
    Leonhardt U; Ritzel U; Ramadori G
    Internist (Berl); 1996 Sep; 37(9):944-9; discussion 949. PubMed ID: 8964694
    [No Abstract]   [Full Text] [Related]  

  • 10. [Pantoprazole. A new acid pump inhibitor against peptic ulcer and reflux esophagitis].
    Wilson BV; Knudsen T
    Ugeskr Laeger; 1996 Mar; 158(12):1695-7. PubMed ID: 8644421
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of pantoprazole versus other proton pump inhibitors on 24-hour intragastric pH and basal acid output in Zollinger-Ellison syndrome.
    Ramdani A; Mignon M; Samoyeau R
    Gastroenterol Clin Biol; 2002 Apr; 26(4):355-9. PubMed ID: 12070410
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proton-pump inhibitors for gastric acid-related disease.
    Franko TG; Richter JE
    Cleve Clin J Med; 1998 Jan; 65(1):27-34. PubMed ID: 9465453
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Do other proton pump blockers have advantages over Antra (omeprazole)?].
    Creutzfeldt W
    Internist (Berl); 1996 Sep; 37(9):936-7. PubMed ID: 8964689
    [No Abstract]   [Full Text] [Related]  

  • 14. Long-term treatment with lansoprazole for patients with Zollinger-Ellison syndrome.
    Hirschowitz BI; Mohnen J; Shaw S
    Aliment Pharmacol Ther; 1996 Aug; 10(4):507-22. PubMed ID: 8853754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The changing role of H2-receptor antagonists in acid-related diseases.
    Lamers CB
    Eur J Gastroenterol Hepatol; 1996 Oct; 8 Suppl 1():S3-7. PubMed ID: 8930573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lansoprazole and omeprazole in the treatment of acid peptic disorders.
    Blum RA
    Am J Health Syst Pharm; 1996 Jun; 53(12):1401-15. PubMed ID: 8781686
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential uses of intravenous proton pump inhibitors to control gastric acid secretion.
    Metz DC
    Digestion; 2000; 62(2-3):73-81. PubMed ID: 11025353
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pantoprazole: an update of its pharmacological properties and therapeutic use in the management of acid-related disorders.
    Cheer SM; Prakash A; Faulds D; Lamb HM
    Drugs; 2003; 63(1):101-33. PubMed ID: 12487624
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Lansoprazol ++ : a new proton pump inhibitor].
    Baczek J; Laskowiec G
    Pol Merkur Lekarski; 1998 Jun; 4(24):339-41. PubMed ID: 9771021
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lansoprazole. An update of its pharmacological properties and clinical efficacy in the management of acid-related disorders.
    Langtry HD; Wilde MI
    Drugs; 1997 Sep; 54(3):473-500. PubMed ID: 9279507
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.